VLS Stock Overview
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
NewNotes are coming soon
Vita Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.51 |
| 52 Week High | AU$2.60 |
| 52 Week Low | AU$1.35 |
| Beta | 0.43 |
| 1 Month Change | 11.07% |
| 3 Month Change | -3.53% |
| 1 Year Change | -16.16% |
| 3 Year Change | 138.89% |
| 5 Year Change | 67.22% |
| Change since IPO | 785.29% |
Recent News & Updates
Recent updates
A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)
Dec 20
Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?
Aug 24If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late
May 14Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?
Mar 18Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?
Feb 17Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?
Jan 20Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching
Dec 22Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Nov 19
Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares
Jul 14Shareholder Returns
| VLS | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | -0.3% | -4.4% | 0.6% |
| 1Y | -16.2% | -25.2% | 3.5% |
Return vs Industry: VLS exceeded the Australian Pharmaceuticals industry which returned -25.2% over the past year.
Return vs Market: VLS underperformed the Australian Market which returned 3.5% over the past year.
Price Volatility
| VLS volatility | |
|---|---|
| VLS Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 15.7% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: VLS is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: VLS's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | n/a | Andrew O'Keefe | https://vitalifesciences.com |
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; pregnancy and breastfeeding; men, women, and children’s health; antioxidant; and bones and joints.
Vita Life Sciences Limited Fundamentals Summary
| VLS fundamental statistics | |
|---|---|
| Market Cap | AU$85.07m |
| Earnings (TTM) | AU$8.25m |
| Revenue (TTM) | AU$64.11m |
10.3x
P/E Ratio1.3x
P/S RatioIs VLS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VLS income statement (TTM) | |
|---|---|
| Revenue | AU$64.11m |
| Cost of Revenue | AU$26.01m |
| Gross Profit | AU$38.10m |
| Other Expenses | AU$29.85m |
| Earnings | AU$8.25m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 59.42% |
| Net Profit Margin | 12.86% |
| Debt/Equity Ratio | 0% |
How did VLS perform over the long term?
See historical performance and comparison